ANASTASIA MCCOY: Open Payments
NPI 1518725605 · ELKTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 20 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $36 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Lilly USA, LLC | 3 | $47 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $31 |
| Tactile Systems Technology Inc | 1 | $24 |
| Exact Sciences Corporation | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: Wegovy, FARXIGA, JARDIANCE, XIFAXAN, Flexitouch Plus, The Cologuard Plus Collection Kit, VOQUEZNA, CAPVAXIVE.
Industry payments across MD — which companies pay providers there.
